The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients died, the drug’s manufacturer halted dosing under pressure from the FDA.

Despite regulatory setbacks, the petitioners believe that survival and other data they've collected themselves are worth ...

Mount Sinai Medical Center today announced a transformational $15 million gift from Kenneth C. Griffin, founder and CEO of ...

What if feeling emotionally safe at the doctor’s office was just as critical as sterile tools? Discover why emotional safety ...

Zhang and fellow students are benefiting from enhanced skill development as a result of a new type of position at the School, ...

As hospitals and health systems push to reduce friction in clinical workflows, EHR optimization has become mission-critical. Seven executives at the nation’s largest health systems told Becker’s they ...

A majority of patients with inflammatory bowel disease (IBD) said they felt marijuana and CBD were “beneficial” and provided ...

Billionaire philanthropist and Citadel CEO Ken Griffin has donated $15 million to Mount Sinai Medical Center to help expand ...

A rare dual-nurse role is emerging in the U.S. that could serve as a powerful aid to systems: clinically based nurse scientists. Nurse scientists, also referred to as nurse researchers, are nurses who ...

Mariam Eskander, MD, explores how food insecurity and geographic barriers hinder breast cancer trial participation, ...

As the daughter of New York City school teachers, Dr. Stacey Rosen had two values instilled into her as a child: fairness and ...

A doctor has urged patients to proceed with caution when using cannabis during cancer immunotherapy and called for more ...